We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$53.8M
Cap. Flow
+$5.76M
Cap. Flow %
1.94%
Top 10 Hldgs %
93.43%
Holding
14
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$5.76M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.6B
$76.8M 25.9%
3,939,529
– –
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$61.5M 20.73%
13,104,424
– –
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$37.9M 12.8%
3,008,243
– –
PMVP icon
4
PMV Pharmaceuticals
PMVP
$57.1M
$19.7M 6.66%
1,385,807
– –
TYRA icon
5
Tyra Biosciences
TYRA
$1.84B
$18M 6.07%
2,518,582
– –
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$17.7M 5.98%
263,914
+90,614
+52% +$5.76M
CGEM icon
7
Cullinan Oncology
CGEM
$1.04B
$15.7M 5.28%
1,221,145
– –
ARVN icon
8
Arvinas
ARVN
$534M
$12.1M 4.08%
287,251
– –
BPMC
9
DELISTED
Blueprint Medicines
BPMC
$9.51M 3.21%
188,228
– –
SPRY icon
10
ARS Pharmaceuticals
SPRY
$573M
$8.1M 2.73%
1,910,029
– –
RLAY icon
11
Relay Therapeutics
RLAY
$3.99B
$7.96M 2.69%
475,485
– –
KRON
12
DELISTED
Kronos Bio
KRON
$5.28M 1.78%
1,451,537
– –
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.38M 1.14%
611,310
– –
CCCC icon
14
C4 Therapeutics
CCCC
$391M
$2.83M 0.96%
375,857
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q2 2022 Portfolio in Review

As of Q2 2022, Nextech Invest held 14 positions worth $296M, down 15% from $350M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Nextech Invest opened no new positions and made no exits, leaving the 14-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nextech Invest added most to Mirati Therapeutics, Inc. Common Stock in Q2 2022, an estimated $5.76M increase.
  • Nextech Invest's ten largest holdings make up 93% of its $296M portfolio in Q2 2022.
  • Nextech Invest opened 0 new positions and closed 0 in Q2 2022.
  • Nextech Invest's portfolio value fell 15% quarter-over-quarter to $296M.

Based on Nextech Invest's 13F filing for Q2 2022, filed 1 Aug 2022.